Li xia Yang

Summary

Country: China

Publications

  1. Xi Y, Liu B, Yang L, Kuang C, Guo R. Changes in levels of angiotensin II and its receptors in a model of inverted stress-induced cardiomyopathy. Eur J Med Res. 2014;19:54 pubmed publisher
    ..05). Expression of angiotensin II, its receptors, ACE-II and angiotensin (1-7) was altered in response to SIC. The renin-angiotensin system could represent a therapeutic target in the prevention of SIC. ..
  2. Yang Y, Yang L. Identification of Rab6a as a New Target of microRNA-155 Involved in Regulating Lipopolysaccharide-Induced TNF Secretion. Inflammation. 2016;39:107-112 pubmed publisher
  3. Yang L, Zhou X, Guo R, Shi Y, Liang X, Heng X. Role of Kr├╝ppel-like factor 2 and protease-activated receptor-1 in vulnerable plaques of ApoE(-/-) mice and intervention with statin. Can J Cardiol. 2013;29:997-1005 pubmed publisher
    ..Plaque vulnerability correlated negatively with KLF2 but positively with PAR-1. Upregulation of KLF2 and downregulation of PAR-1 could be direct or indirect effects of statin therapy. ..
  4. Yang L, Yang Z, Guo R, Ye J, Liu H. Angiotensin II induces extracellular matrix metalloproteinase inducer expression via an AT1R dependent pathway in aortic atherosclerotic plaque in apolipoprotein E knockout mice. J Renin Angiotensin Aldosterone Syst. 2012;13:67-75 pubmed publisher
    ..Ang II up-regulated EMMPRIN expression in atherosclerotic plaque via AT1R, and valsartan could inhibit the effect of Ang II. ..